(TALK) Talkspace - Overview
Stock: Therapy, Psychiatry, Counseling, Messaging, Video
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 55.9% |
| Relative Tail Risk | -6.29% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.33 |
| Alpha | -8.11 |
| Character TTM | |
|---|---|
| Beta | 1.047 |
| Beta Downside | 0.781 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.35% |
| CAGR/Max DD | 1.09 |
Description: TALK Talkspace December 27, 2025
Talkspace, Inc. (NASDAQ:TALK) is a U.S.–based virtual behavioral health provider that links patients with licensed therapists and psychiatrists via an online platform offering messaging, audio, and video sessions. The service covers a range of conditions-including depression, anxiety, and trauma-and is delivered to individual subscribers, health-insurance plans, employee assistance programs, and enterprise clients. Founded in 2012 and rebranded from Groop Internet Platform Inc. in June 2021, the company is headquartered in New York.
As of Q3 2024, Talkspace reported revenue of roughly $79 million, up about 12% year-over-year, and a subscriber base exceeding 1.2 million users, though it posted a net loss of $30 million, reflecting ongoing investment in technology and marketing. Growth is being driven by expanding employer-sponsored mental-health benefits, broader insurance coverage for tele-therapy, and a telehealth market that is projected to expand at a ~20% CAGR through 2028. The broader health-care equipment sub-industry is benefiting from sustained digital-health adoption post-COVID-19 and favorable regulatory trends that reimburse virtual therapy services.
For a deeper dive into Talkspace’s valuation metrics, you might find the ValueRay platform’s analyst notes useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 4.24m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.01 > 0.02 and ΔFCF/TA -2.97 > 1.0 |
| NWC/Revenue: 44.32% < 20% (prev 62.04%; Δ -17.72% < -1%) |
| CFO/TA 0.06 > 3% & CFO 7.24m > Net Income 4.24m |
| Net Debt (-39.5m) to EBITDA (7.35m): -5.38 < 3 |
| Current Ratio: 5.91 > 1.5 & < 3 |
| Outstanding Shares: last quarter (173.8m) vs 12m ago -1.40% < -2% |
| Gross Margin: 43.32% > 18% (prev 0.47%; Δ 4285 % > 0.5%) |
| Asset Turnover: 160.6% > 50% (prev 131.2%; Δ 29.42% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBITDA TTM and Interest Expense TTM) |
Altman Z'' -15.00
| A: 0.74 (Total Current Assets 114.5m - Total Current Liabilities 19.4m) / Total Assets 129.1m |
| B: -2.06 (Retained Earnings -266.2m / Total Assets 129.1m) |
| C: 0.03 (EBIT TTM 4.44m / Avg Total Assets 133.6m) |
| D: -13.34 (Book Value of Equity -266.1m / Total Liabilities 20.0m) |
| Altman-Z'' Score: -15.67 = D |
Beneish M -2.99
| DSRI: 1.31 (Receivables 14.9m/9.60m, Revenue 214.6m/181.3m) |
| GMI: 1.09 (GM 43.32% / 47.10%) |
| AQI: 0.31 (AQ_t 0.01 / AQ_t-1 0.05) |
| SGI: 1.18 (Revenue 214.6m / 181.3m) |
| TATA: -0.02 (NI 4.24m - CFO 7.24m) / TA 129.1m) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of TALK shares?
Over the past week, the price has changed by -3.96%, over one month by -1.02%, over three months by +14.45% and over the past year by +7.78%.
Is TALK a buy, sell or hold?
- StrongBuy: 6
- Buy: 0
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TALK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5 | 28.9% |
| Analysts Target Price | 5 | 28.9% |
| ValueRay Target Price | 4 | 4.1% |
TALK Fundamental Data Overview February 05, 2026
P/E Forward = 33.67
P/S = 3.145
P/B = 6.134
Revenue TTM = 214.6m USD
EBIT TTM = 4.44m USD
EBITDA TTM = 7.35m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -39.5m USD (from netDebt column, last quarter)
Enterprise Value = 583.3m USD (674.9m + (null Debt) - CCE 91.6m)
Interest Coverage Ratio = unknown (Ebit TTM 4.44m / Interest Expense TTM 0.0)
EV/FCF = -327.5x (Enterprise Value 583.3m / FCF TTM -1.78m)
FCF Yield = -0.31% (FCF TTM -1.78m / Enterprise Value 583.3m)
FCF Margin = -0.83% (FCF TTM -1.78m / Revenue TTM 214.6m)
Net Margin = 1.98% (Net Income TTM 4.24m / Revenue TTM 214.6m)
Gross Margin = 43.32% ((Revenue TTM 214.6m - Cost of Revenue TTM 121.6m) / Revenue TTM)
Gross Margin QoQ = 41.68% (prev 43.07%)
Tobins Q-Ratio = 4.52 (Enterprise Value 583.3m / Total Assets 129.1m)
Interest Expense / Debt = unknown (Interest Expense 1.18m / Debt none)
Taxrate = 0.76% (25.0k / 3.28m)
NOPAT = 4.40m (EBIT 4.44m * (1 - 0.76%))
Current Ratio = 5.91 (Total Current Assets 114.5m / Total Current Liabilities 19.4m)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = -5.38 (Net Debt -39.5m / EBITDA 7.35m)
Debt / FCF = 22.18 (negative FCF - burning cash) (Net Debt -39.5m / FCF TTM -1.78m)
Total Stockholder Equity = 113.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.17% (Net Income 4.24m / Total Assets 129.1m)
RoE = 3.75% (Net Income TTM 4.24m / Total Stockholder Equity 113.2m)
RoCE = 4.05% (EBIT 4.44m / Capital Employed (Total Assets 129.1m - Current Liab 19.4m))
RoIC = 3.89% (NOPAT 4.40m / Invested Capital 113.2m)
WACC = 9.77% (E(674.9m)/V(674.9m) * Re(9.77%) + (debt-free company))
Discount Rate = 9.77% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.85%
Fair Price DCF = unknown (Cash Flow -1.78m)
EPS Correlation: 88.44 | EPS CAGR: 68.32% | SUE: -2.07 | # QB: 0
Revenue Correlation: 98.14 | Revenue CAGR: 20.87% | SUE: 1.24 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.03 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=0.15 | Chg30d=N/A | Revisions Net=+1 | Growth EPS=+66.7% | Growth Revenue=+22.3%